A pilot randomized trial comparing long-term effects of red and white wines on biomarkers of atherosclerosis (in vino veritas: IVV trial)

Bratislava Medical Journal

Volumn 113, Issue 3, 2012, Pages 156-158

  Taborsky, M ^a   Ostadal, P ^b   Petrek, M ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Atherosclerosis; HDL cholesterol; Red wine; White wine

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METHODOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; WINE;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; RESEARCH DESIGN; WINE;

EID: 84871733075     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2012_037     Document Type: Article

References (21)

1. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339 (8808): 1523-1526.
2. Das S, Santani DD, Dhalla NS. Experimental evidence for the cardioprotective effects of red wine. Exp Clin Cardiol 2007; 12 (1): 5-10.
3. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA, Jr., Stampfer MJ, Willett WC et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348 (2): 109-118.
4. Samanek M, Dobiasova M, Urbanova Z, Kaspar Z, Omacka A. [Consumption of white wine retards development of atherosclerosis and affects anticoagulation]. Cas Lek Cesk 2002; 141 (8): 251-254.
5. Kalkan Yildirim H, Delen Akcay Y, Guvenc U, Yildirim Sozmen E. Protection capacity against low-density lipoprotein oxidation and antioxidant potential of some organic and non-organic wines. Int J Food Sci Nutr 2004; 55 (5): 351-362.
6. Jamroz A, Beltowski J. Antioxidant capacity of selected wines. Med Sci Monit 2001; 7 (6): 1198-1202.
7. Landrault N, Poucheret P, Ravel P, Gasc F, Cros G, Teissedre PL. Antioxidant capacities and phenolics levels of French wines from different varieties and vintages. J Agric Food Chem 2001; 49 (7): 3341-3348.
8. Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Bohm M. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox". FASEB J 2002; 16 (14): 1958-1960.
9. Sparwel J, Vantler M, Caglayan E, Kappert K, Fries JW, Dietrich H, et al. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation. Cardiovasc Res 2009; 81 (4): 758-770.
10. Munday JS, Thompson KG, James KA, Manktelow BW. The effect of moderate alcohol consumption as either red or white wine in the C57BL/6 mouse atherosclerosis model. Coron Artery Dis 1999; 10 (2): 97-102.
11. Lopez D, Pavelkova M, Gallova L, Simonetti P, Gardana C, Lojek A, et al. Dealcoholized red and white wines decrease oxidative stress associated with inflammation in rats. Br J Nutr 2007; 98 (3): 611-619.
12. Auger C, Rouanet JM, Vanderlinde R, Bornet A, Decorde K, Lequeux N, et al. Polyphenols-enriched Chardonnay white wine and sparkling Pinot Noir red wine identically prevent early atherosclerosis in hamsters. J Agric Food Chem 2005; 53 (25): 9823-9829.
13. Tousoulis D, Ntarladimas I, Antoniades C, Vasiliadou C, Tentolouris C, Papageorgiou N, et al. Acute effects of different alcoholic beverages on vascular endothelium, inflammatory markers and thrombosis fibrinolysis system. Clin Nutr 2008; 27 (4): 594-600.
14. Pignatelli P, Ghiselli A, Buchetti B, Carnevale R, Natella F, Germano G, et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 2006; 188 (1): 77-83.
15. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996; 246 (1-2): 163-182.
16. Pinzani P, Petruzzi E, MagnolfiSU, Malentacchi F, De Siena G, Petruzzi I, et al. Red or white wine assumption and serum antioxidant capacity. Arch Gerontol Geriatr 2010.
17. Williams MJ, Sutherland WH, Whelan AP, McCormick MP, de Jong SA. Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease. Metabolism
18. Whelan AP, Sutherland WH, McCormick MP, Yeoman DJ, de Jong SA, Williams MJ. Effects of white and red wine on endothelial function in subjects with coronary artery disease. Intern Med J 2004; 34 (5): 224-822.
19. Blann AD, Williams NR, Lip GY, Rajput-Williams J, Howard AN. Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine. Blood Coagul Fibrinolysis 2002; 13 (7): 647-651.
20. Sacanella E, Vazquez-Agell M, Mena MP, Antunez E, Fernandez-Sola J, Nicolas JM, et al. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am J Clin Nutr 2007; 86 (5): 1463-1469.
21. Ronksley PE, Brien SE, Turner B, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011: 342; 671. doi: 10.1136/bmj.d671.